|Awarded On||September 14, 2016|
|Title||North Texas Clinical Pharmacology Cancer Core|
|Award Mechanism||Core Facilities Support Awards - Competitive Renewal|
|Institution/Organization||Texas Tech University Health Sciences Center|
|Principal Investigator/Program Director||William Putnam|
|Cancer Sites||All Sites|
There is urgent need for translating basic cancer research (discovery) results into improved care for cancer patients and/or better interventional tools to cure and/or prevent cancer. A state-of-the-art analytical facility has been established (North Texas Clinical Pharmacology Cancer Core) to help basic cancer researchers and physicians better test new drugs or new therapies. Such testing will assist investigators to better understand how cancer drugs work in the body, how the drugs treat cancer, and how to avoid unwanted effects of cancer drugs. In general, the research team of this core will support translational researchers to do research on what cancer drugs do to the body, and what the...